• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性一生中的生殖里程碑与心血管疾病风险。

Reproductive milestones across the lifespan and cardiovascular disease risk in women.

机构信息

Department of Medicine, Division of Endocrinology and Metabolism, UC San Diego School of Medicine, La Jolla, CA, USA.

出版信息

Climacteric. 2024 Feb;27(1):5-15. doi: 10.1080/13697137.2023.2259793. Epub 2024 Jan 15.

DOI:10.1080/13697137.2023.2259793
PMID:37769699
Abstract

Cardiovascular disease (CVD) is the leading cause of death for women across the developed and developing world. Beyond traditional cardiovascular risk factors, a number of reproductive milestones have been recognized. The goal of this White Paper, issued by the International Menopause Society in conjunction with World Menopause Day 2023, is to highlight female reproductive milestones in terms of potential cardiovascular risk and to review recommendations for minimizing that risk. The primary milestones discussed relate to menstrual cyclicity, adverse pregnancy outcomes, breast cancer treatments and menopause. Each of these categories has a number of permutations that have been shown in observational studies to be associated with increased cardiovascular risks. In current clinical care, recognition of these reproductive milestones has been encouraged so patients can be informed and motivated to engage in primary prevention of CVD early in their life course rather than retrospectively later in life. Options for specifically targeted care with specialist teams are designed to enhance success with risk identification, screening and possible detection of CVD and, optimally, primary or secondary prevention of CVD. Promoting cardiovascular health of women has far-reaching effects for themselves, their families and their progeny. It is time to make women's cardiovascular health a priority.

摘要

心血管疾病(CVD)是发达和发展中国家女性的主要死因。除了传统的心血管危险因素外,许多生殖里程碑已经得到认可。本白皮书由国际绝经学会与 2023 年世界绝经日联合发布,旨在强调女性生殖里程碑与潜在心血管风险的关系,并回顾减少这种风险的建议。主要讨论的里程碑与月经周期、不良妊娠结局、乳腺癌治疗和绝经有关。这些类别中的每一个都有许多组合,观察性研究表明这些组合与心血管风险增加有关。在当前的临床护理中,已经鼓励认识到这些生殖里程碑,以便患者能够了解并积极主动地在其生命早期进行 CVD 的一级预防,而不是在以后的生活中回顾性地进行。与专家团队合作的特定针对性护理方案旨在提高风险识别、筛查和 CVD 可能检测的成功率,并优化 CVD 的一级或二级预防。促进女性的心血管健康对她们自己、她们的家庭和后代都有深远的影响。现在是将女性的心血管健康作为优先事项的时候了。

相似文献

1
Reproductive milestones across the lifespan and cardiovascular disease risk in women.女性一生中的生殖里程碑与心血管疾病风险。
Climacteric. 2024 Feb;27(1):5-15. doi: 10.1080/13697137.2023.2259793. Epub 2024 Jan 15.
2
Women's Reproductive Milestones and Cardiovascular Disease Risk: A Review of Reports and Opportunities From the CARDIA Study.女性生殖里程碑与心血管疾病风险:来自 CARDIA 研究的报告和机会综述。
J Am Heart Assoc. 2023 Mar 7;12(5):e028132. doi: 10.1161/JAHA.122.028132. Epub 2023 Feb 27.
3
Menopause Characteristics, Total Reproductive Years, and Risk of Cardiovascular Disease Among Chinese Women.中国女性的绝经特征、总生育年限与心血管疾病风险
Circ Cardiovasc Qual Outcomes. 2017 Nov;10(11):e004235. doi: 10.1161/CIRCOUTCOMES.117.004235.
4
Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association.绝经过渡期与心血管疾病风险:早期预防时机的影响——美国心脏协会科学声明。
Circulation. 2020 Dec 22;142(25):e506-e532. doi: 10.1161/CIR.0000000000000912. Epub 2020 Nov 30.
5
[WOMEN'S CARDIAC HEALTH - FROM THEORY TO ACTIVISM].[女性心脏健康——从理论到行动主义]
Harefuah. 2017 Apr;156(4):246-249.
6
Duration of Reproductive Life Span, Age at Menarche, and Age at Menopause Are Associated With Risk of Cardiovascular Disease in Women.生殖寿命、初潮年龄和绝经年龄与女性心血管疾病风险相关。
J Am Heart Assoc. 2017 Nov 2;6(11):e006713. doi: 10.1161/JAHA.117.006713.
7
Hormones and cardiovascular health in women.女性体内的激素与心血管健康
Hum Reprod Update. 2006 Sep-Oct;12(5):483-97. doi: 10.1093/humupd/dml028. Epub 2006 Jun 28.
8
What the Women's Health Initiative has taught us about menopausal hormone therapy.妇女健康倡议组织关于绝经激素治疗给我们带来的启示。
Clin Cardiol. 2018 Feb;41(2):247-252. doi: 10.1002/clc.22891. Epub 2018 Mar 1.
9
Is cardiovascular disease in women inevitable?: preparing for menopause and beyond.女性的心血管疾病不可避免吗?:为绝经及绝经后做准备。
Cardiol Rev. 2011 Mar-Apr;19(2):76-80. doi: 10.1097/CRD.0b013e318209a711.
10
Hormone therapy in menopause: An update on cardiovascular disease considerations.绝经期激素治疗:心血管疾病相关问题的最新进展。
Trends Cardiovasc Med. 2015 Aug;25(6):540-9. doi: 10.1016/j.tcm.2015.01.008. Epub 2015 Feb 12.

引用本文的文献

1
Representation of women in cardiovascular disease management: a systematic analysis of ESC guidelines.心血管疾病管理中女性的呈现:对欧洲心脏病学会指南的系统分析
Open Heart. 2025 Sep 1;12(2):e003320. doi: 10.1136/openhrt-2025-003320.
2
Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome.超越激素:多囊卵巢综合征中心血管疾病风险的系统评价
Cureus. 2024 Nov 4;16(11):e72987. doi: 10.7759/cureus.72987. eCollection 2024 Nov.
3
Teaching gender medicine can enhance the quality of healthcare.
教授性别医学可以提高医疗保健质量。
Am Heart J Plus. 2024 Jun 25;44:100418. doi: 10.1016/j.ahjo.2024.100418. eCollection 2024 Aug.
4
A Survey on Relation of Menopause to Metabolic Syndrome - SAFOMS STUDY (South Asian Federation of Menopause Societies) - Interim Analysis.绝经与代谢综合征关系的调查——SAFOMS研究(南亚绝经学会联合会)——中期分析
J Midlife Health. 2023 Oct-Dec;14(4):291-298. doi: 10.4103/jmh.jmh_17_24. Epub 2024 Feb 23.
5
Changing Care in Changing World - Reproductive Marker of Cardiovascular Disease Risk in Women.变化世界中的医疗变革——女性心血管疾病风险的生殖标志物
J Midlife Health. 2023 Jul-Sep;14(3):149-151. doi: 10.4103/jmh.jmh_248_23. Epub 2023 Dec 30.